Abstract
Materials and methods Patients were consecutively recruited among the patients with pSS seen in our rheumatic department between March 2001 and October 2007. All the included patients met the revised European Community Criteria for pSS. All patients fulfilling the clinical criteria for rheumatoid arthritis (RA), SLE, polymyositis, systemic sclerosis or other diffuse connective tissue diseases were excluded from pSS group. Any patients with sarcoidosis, graft-versus-host disease, acquired immune deficiency syndrome or preexisting lymphoma were also excluded.
Highlights
Open AccessFrequency and significance of anticardiolipin antibodies in Chinese patients with primary Sjögren's syndrome
ACL antibodies are often found in serum samples from patients with primary Sjögren's syndrome, their clinical significance remains unclear
15th Paediatric Rheumatology European Society (PreS) Congress Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here.
Summary
Frequency and significance of anticardiolipin antibodies in Chinese patients with primary Sjögren's syndrome. Address: Xiangmihu Branch of Shenzhen Fourth People's Hospital, Shenzhen, Guangdong, PR China * Corresponding author from 15th Paediatric Rheumatology European Society (PreS) Congress London, UK. Published: 15 September 2008 Pediatric Rheumatology 2008, 6(Suppl 1):P240 doi:10.1186/1546-0096-6-S1-P240. 15th Paediatric Rheumatology European Society (PreS) Congress Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
